Filter by patients with: All

What is Cu-ATSM?

Category: Others

false

Cu-ATSM is a copper compound that may be used as a therapeutic agent to prevent cells from developing malformed proteins.

See patients taking Cu-ATSM

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Amyotrophic lateral sclerosis 8 13
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 14 patients that have used Cu-ATSM

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 13

Commonly reported side effects and conditions associated with Cu-ATSM

Side effect Patients Percentage
Neuropathic pain in lower extremities 1

Why patients stopped taking Cu-ATSM

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 1
Other 1
See 1 patient who's stopped using Cu-ATSM

Duration

Stopped using Cu-ATSM

Duration Patients Percentage
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 12
Usually 0
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 10
Cost per month
Cost per month Evaluations Percentage
$200+ 11
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 1
Last updated:

1 patient evaluation for Cu-ATSM

Sort by: Most recent

Apr 30, 2017 (Started Dec 05, 2016)

  • Effectiveness
    Moderate (for amyotrophic lateral sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 18 mg Daily
Cost: $200+ monthly

Jan 2, 2017 (Started Dec 05, 2016)

  • Effectiveness
    Slight (for amyotrophic lateral sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 12 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $200+ monthly
  • 3 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Cu-ATSM